Continued complete remission of Merkel cell carcinoma with in-transit metastasis after treatment with isolated limb perfusion regional chemotherapy;Rémission complète persistante d'une tumeur de Merkel avec métastases satellites après traitement par chimiothérapie locorégionale de type membre perfusé isolé

Annales de Dermatologie et de Venereologie

Volumn 133, Issue 8-9, 2006, Pages 700-703

  Grandpeix, C ^a   Bonvalot, S ^a   Petrow, P ^b   Fraitag, S ^c   Gounod, N ^d   Avril, M F ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT CURIE   (France)

^c Cabinet de Dermatopathologie   (France)

^d Cabinet de Dermatologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MELPHALAN;

AGED; ANKLE; ARTICLE; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER REGRESSION; CANCER RELAPSE; CASE REPORT; FEMALE; HUMAN; JOINT STIFFNESS; LEG; LEG AMPUTATION; LYMPH NODE METASTASIS; MERKEL CELL TUMOR; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; PIGMENTATION; SCLERODERMA; SIDE EFFECT; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; VISCERAL METASTASIS;

EID: 33748748043     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(06)70996-6     Document Type: Article

References (14)

1. Poulsen M. Merkel cell carcinoma of the skin. Lancet Oncol 2004;5:593-9.
2. Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002;20:588-98.
3. Eng T, Boersma MG, Fuller CD, Cavanaugh SX, Valenzuela F, Herman TS. Treatment of Merkel cell carcinoma. Am J Clin Oncol 2004;27:510-5.
4. Herbst A, Haynes HA, Nghiem P. The standard of care for Merkel cell carcinoma should include adjuvant radiation and lymph node surgery. J Am Acad Dermatol 2002;46:640-2.
5. Creech O, Krementz E, Ryan E, Winblad J. Chemotherapy of cancer: regional perfusion utilising an extracorporeal circuit. Ann Surg 1958;148:616-32.
6. Bonvalot S, Laplanche A, Lejeune F, Stoeckle E, Le Pechoux C, Vanel D, et al. Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF α be better? Ann Oncol 2005;16:1061-8.
7. Vrouenraets BC, Eggermont AM, Hart AM, Klaase JM, Van Geel AN, Nieweg OE, et al. Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor-α versus toxicity after melphalan alone. Eur J Surg Oncol 2001;27:390-5.
8. Dawson R, Williams OM, Mansel RE. Isolated hyperthermic limb perfusion chemotherapy in Merkel cell tumour: a case report. J R Coll Surg Edimb 1996;41:255-6.
9. Gupta AS, Heinzman S, Levine EA. Successful treatment of in-transit metastasis from Merkel's cell carcinoma with isolated hyperthermic limb perfusion. South Med J 1998;91:289-92.
10. Olieman AF, Lienard D, Eggermont AM, Kroon BB, Lejeune FJ, Hoekstra HJ, et al. Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced non melanoma skin tumors of the extremities: a multicenter study. Arch Surg 1999;134:303-7.
11. Nourda EM, Vrouenraets BC, Nieweg OE, Van Geel AN, Eggermont AM, Kroon BB. Safety and efficacy of isolated limb perfusion in elderly melanoma patients. Ann Surg Oncol 2002;9:968-74.
12. Van Etten B, Van Geel AN, De Wilt JH, Eggermont AM. Fifty tumor necrosis factor-based isolated limb perfusions for limb salvage in patients older than 75 years with limb-threatening soft tissue sarcomas and other extremity tumors. Ann Surg Oncol 2003;10:32-7.
13. Klicks RJ, Vrouenraets BC, Nieweg OE, Kroon BB. Vascular complications of isolated limb perfusion. Eur J Surg Oncol 1998;24:288-91.
14. Sonneveld EJ, Vrouenraets BC, Van Geel BN, Eggermont AM, Klaase JM, Nieweg OE, et al. Systemic toxicity after isolated limb perfusion with melphalan for melanoma. Eur J Surg Oncol 1996;22:521-7.